| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.005 |